AMRX Amneal Pharmaceuticals Inc

Price (delayed)

$13.55

Market cap

$4.32B

P/E Ratio

34.74

Dividend/share

N/A

EPS

$0.39

Enterprise value

$6.82B

?
Relative Growth: Rel. Growth: 78
Relative Strength: Rel. Strength: 71
Relative Valuation: Rel. Valuation: 82
Relative Profitability: Rel. Profitability: 55

Amneal Pharmaceuticals, Inc., headquartered in Bridgewater, NJ, is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and specialty drug products. The Company has operations in ...

Highlights
AMRX's quick ratio has soared by 91% YoY and by 6% from the previous quarter
The P/E is 91% below the last 4 quarters average of 349.0
AMRX's debt is up by 4.5% year-on-year

Key stats

What are the main financial stats of AMRX

AMRX stock price

How has the Amneal Pharmaceuticals stock price performed over time
Intraday
5.24%
1 week
4.63%
1 month
3.36%
1 year
87.93%
YTD
7.54%
QTD
9.01%

Financial performance

How have Amneal Pharmaceuticals's revenue and profit performed over time
Revenue
$3.05B
Gross profit
$1.18B
Operating income
$435.52M
Net income
$122.12M
Gross margin
38.7%
Net margin
4%
The company's net income has surged by 69% QoQ
AMRX's net margin has surged by 67% since the previous quarter
The company's operating income rose by 21% YoY and by 11% QoQ
The operating margin is up by 13% year-on-year and by 9% since the previous quarter

Price vs fundamentals

How does AMRX's price correlate with its fundamentals

Growth

What is Amneal Pharmaceuticals's growth rate over time

Valuation

What is Amneal Pharmaceuticals stock price valuation
P/E
34.74
P/B
N/A
P/S
1.41
EV/EBIT
18.93
EV/EBITDA
12.03
EV/Sales
2.24
The P/E is 91% below the last 4 quarters average of 349.0
AMRX's EPS has soared by 70% since the previous quarter
Amneal Pharmaceuticals's equity has surged by 66% YoY and by 36% QoQ
The price to sales (P/S) is 123% higher than the 5-year quarterly average of 0.6 and 22% higher than the last 4 quarters average of 1.1
AMRX's revenue is up by 8% year-on-year

Efficiency

How efficient is Amneal Pharmaceuticals business performance
The company's return on assets has surged by 70% QoQ
AMRX's ROS is up by 27% year-on-year and by 10% since the previous quarter
AMRX's ROIC is up by 23% YoY and by 6% from the previous quarter

Dividends

What is AMRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMRX.

Financial health

How did Amneal Pharmaceuticals financials performed over time
AMRX's quick ratio has soared by 91% YoY and by 6% from the previous quarter
The company's current ratio has surged by 76% YoY and by 14% QoQ
Amneal Pharmaceuticals's equity has surged by 66% YoY and by 36% QoQ
The company's debt to equity has shrunk by 56% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.